Decibel Therapeutics, Inc. Operating Expenses
Decibel Therapeutics, Inc. reported Operating Expenses of $19.04 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-08-11
- Decibel Therapeutics, Inc. operating expenses for the quarter ending 2023-06-30 was $19.04M, a 11.33% increase year-over-year.
- Decibel Therapeutics, Inc. operating expenses for the quarter ending 2023-03-31 was $14.12M, a 0.73% increase year-over-year.
- Decibel Therapeutics, Inc. operating expenses for the quarter ending 2022-12-31 was $16.49M, a 27.78% increase year-over-year.
- Decibel Therapeutics, Inc. operating expenses for the quarter ending 2022-09-30 was $16.35M, a 11.22% increase year-over-year.
- Decibel Therapeutics, Inc. operating expenses for fiscal 2022 was $63.96M, a 27.33% increase from fiscal 2021.
- Decibel Therapeutics, Inc. operating expenses for fiscal 2021 was $50.23M, a 26.96% increase from fiscal 2020.
- Decibel Therapeutics, Inc. operating expenses for fiscal 2020 was $39.56M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-06-30 | $19.04M 10-Q · filed 2023-08-11 | $33.16M 10-Q · filed 2023-08-11 | $49.65M derived: sum of 3 quarters · filed 2023-08-11 | $66.00M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $14.12M 10-Q · filed 2023-05-15 | $30.61M derived: sum of 2 quarters · filed 2023-05-15 | $46.96M derived: sum of 3 quarters · filed 2023-05-15 | $64.06M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $16.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $32.84M derived: sum of 2 quarters · filed 2023-03-14 | $49.94M derived: sum of 3 quarters · filed 2023-08-11 | $63.96M 10-K · filed 2023-03-14 |
| 2022-09-30 | $16.35M 10-Q · filed 2022-11-09 | $33.45M derived: sum of 2 quarters · filed 2023-08-11 | $47.47M 10-Q · filed 2022-11-09 | $60.37M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | $17.10M 10-Q · filed 2023-08-11 | $31.12M 10-Q · filed 2023-08-11 | $44.02M derived: sum of 3 quarters · filed 2023-08-11 | $58.72M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $14.02M 10-Q · filed 2023-05-15 | $26.92M derived: sum of 2 quarters · filed 2023-05-15 | $41.62M derived: sum of 3 quarters · filed 2023-05-15 | $53.35M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $27.60M derived: sum of 2 quarters · filed 2023-03-14 | $39.33M derived: sum of 3 quarters · filed 2023-03-14 | $50.23M 10-K · filed 2023-03-14 |
| 2021-09-30 | $14.70M 10-Q · filed 2022-11-09 | $26.43M derived: sum of 2 quarters · filed 2022-11-09 | $37.33M 10-Q · filed 2022-11-09 | $50.34M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $11.73M 10-Q · filed 2022-08-10 | $22.63M 10-Q · filed 2022-08-10 | $35.64M derived: sum of 3 quarters · filed 2022-08-10 | $42.72M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $10.90M 10-Q · filed 2022-05-12 | $23.91M derived: sum of 2 quarters · filed 2022-05-12 | $31.00M derived: sum of 3 quarters · filed 2022-05-12 | $38.85M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $20.09M derived: sum of 2 quarters · filed 2022-03-18 | $27.95M derived: sum of 3 quarters · filed 2022-03-18 | $39.56M 10-K · filed 2022-03-18 |
| 2020-09-30 | $7.09M 10-Q · filed 2021-11-10 | $14.94M derived: sum of 2 quarters · filed 2021-11-10 | $26.56M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.85M 10-Q · filed 2021-08-10 | $19.47M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $11.61M 10-Q · filed 2021-05-13 |